Phosphatase inhibitor cantharidin blocks adenosine A1receptor anti-adrenergic effect in rat cardiac myocytes

Abstract
Experiments were performed to examine whether the protein phosphatase inhibitor cantharidin blocks the anti-adrenergic effect of adenosine A1receptor stimulation. In electrically stimulated adult rat ventricular myocytes loaded with the intracellular calcium concentration ([Ca2+]i) indicator fluo-3, isoproterenol (10 nM) increased systolic [Ca2+]iby 46%, increased twitch amplitude by 56%, and increased total cellular cAMP content by 140%. The adenosine A1receptor agonist 2-chloro- N6-cyclopentlyadenosine (CCPA) reduced isoproterenol-stimulated [Ca2+]iand contractility by 87 and 80%, respectively, but reduced cAMP content by only 18%. Cantharidin had no effects on myocyte [Ca2+]i, contractility, or cAMP in the absence or presence of isoproterenol but blocked the effects of CCPA on [Ca2+]iand contractility by ∼44%. Cantharidin had no effect on CCPA attenuation of isoproterenol-induced increases in cAMP. Pretreatment with CCPA also reduced the increase in contractile parameters produced by the direct cAMP-dependent protein kinase A (PKA) activator 8-bromocAMP. These results suggest that activation of protein phosphatases mediate, in part, the anti-adrenergic effect of adenosine A1receptor activation in ventricular myocardium.

This publication has 22 references indexed in Scilit: